Enrofloxacin

Enrofloxacin

SCHEMBL6742652

CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1.CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
ALDH1A1 P00352 4/20 1.00
LMNA P02545 3/20 1.00
HPGD P15428 2/20 1.00
HSD17B10 Q99714 2/20 1.00
MAPT P10636 1/20 1.00
TOP2B Q02880 2/20 0.73
CYP1A2 P05177 1/20 0.73
TOP2A P11388 1/20 0.73
CYP2C9 P11712 1/20 0.73
CA1 P00915 1/20 0.63
CA2 P00918 1/20 0.63
PIK3CG P48736 5/20 0.62
PIK3CD O00329 3/20 0.62
PIK3R1 P27986 3/20 0.62
PIK3CA P42336 3/20 0.62
DRD3 P35462 1/20 0.62
HRH3 Q9Y5N1 1/20 0.61
HTT P42858 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Enrofloxacin SCHEMBL29349852 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL17554684 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL149150 1.00 KDM4E (1.00) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL10741694 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL17554678 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL16784595 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL9788077 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL976909 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL8027963 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10
Enrofloxacin SCHEMBL29649713 0.99 KDM4E (0.98) KDM4EALDH1A1LMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078991-A1 TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEM KWOK JESSICA (GB) 2021-04-29 WO disclosed
US-6685935-B1 SUICIDE GENE-CONTAINING STRAINS OF BACTERIA, FUNGI AND PROTISTS; TUMOR SPECIFIC SHIGELLA SPECIES YALE UNIVERSITY 2004-02-03 US disclosed
US-6190657-B1 FOR DIAGNOSIS AND THERAPY OF CANCER YALE UNIVERSITY 2001-02-20 US disclosed
EP-0914137-A2 IN OVO ANTIBIOTIC AND MICROBIAL TREATMENT TO DIMINISH SALMONELLAE POPULATIONS IN AVIANS THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Agriculture (US) 1999-05-12 EP disclosed
WO-1998000151-A2 IN OVO ANTIBIOTIC AND MICROBIAL TREATMENT TO DIMINISH SALMONELLAE POPULATIONS IN AVIANS THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF AGRICULTURE (US) 1998-01-08 WO disclosed